Sansure Biotech (SHA:688289) obtained a medical device registration certificate from China's National Medical Products Administration for its human CYP2C9 gene and VKORC1 gene polymorphism nucleic acid detection kit, according to a Thursday disclosure on the Shanghai Stock Exchange.
The certificate is valid until Sept, 9, 2029, the Chinese medical laboratory equipment manufacturer said.
Price (RMB): ¥17.19, Change: ¥+0.010, Percent Change: +0.06%